The term α-synucleinopathies (ASPs) was introduced to categorize a group of disorders that feature pathological α-synuclein (α-syn) accumulations in neuronal and/or glial cells throughout the central nervous system (CNS). The gene discussed is SNCA; the disease is synucleinopathy.